In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


This content is currently on FREE ACCESS, enjoy another 23 days of free consultation

 

CABANA will affect my clinical decision making in atrial fibrillation ablation - PRO

Session Controversies in atrial fibrillation ablation

Speaker Riccardo Cappato

Congress : EHRA 2019

  • Topic : arrhythmias and device therapy
  • Sub-topic : Atrial Fibrillation - Treatment
  • Session type : Debate Session
  • FP Number : 18
15 views

This content is currently on FREE ACCESS, enjoy another 23 days of free consultation

 



Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim, Bristol-Myers Squibb and Pfizer Alliance, and Novartis Pharma AG. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are